Who We Are
Bharat Parenterals Limited leverages over 3 decades of Manufacturing Excellence & has grown into a globally trusted generic and specialty drug manufacturer with a WHO-GMP certified facility backing its operations.
16
Manufacturing Lines
curve bg
40+
Countries
curve bg
32+ Years
Industry Experience
curve bg
25%
Operations Powered By Solar Energy
curve bg
10%
10 Year Revenue CAGR
curve bg
About Us
Our Infrastructural Strength
Our 3,00,000 sq. ft. facility features three independent production blocks, integrated Formulation R&D Laboratory, and a 500+ strong workforce — enabling safe, large-scale manufacturing for diverse global markets with efficiency and precision.
Manufacturing
Our Quality Formulations
We deliver high-quality formulations across injectables, tablets, capsules, and topicals—backed by in-house R&D and uncompromising quality standards across diverse therapeutic areas.
overlay
Explore F&D

One Group. Global Impact.

Bharat Parenterals Limited stands today as the driving force shaping global impact — delivering quality, affordability, and excellence across continents. Through their own operations as well as distinct business models and market focus offered by its group companies - Innoxel & Varenyam Healthcare, Bharat Parenterals have strategically expanded their presence and cater to evolving global market needs with a shared vision for quality and global reach.

World Map

Bharat Parenterals Limited

The backbone of the group—exporting high-quality drug formulations to 40+ countries. With DSIR-recognized R&D and large-scale production facilities, we deliver global standards at scale.

Innoxel Life Sciences Pvt. Ltd.

A next-generation facility focused on breakthrough therapies for global markets. Innoxel develops complex drugs for cancer, neurology, and critical care—tailored for USFDA and EU compliance.

Varenyam Healthcare Pvt. Ltd.

Anchoring our presence in India—bringing trusted branded generics to doctors, hospitals, and patients. Varenyam blends reach with speed, delivering quality medicines across therapeutic categories.

From care to cure

ORAL SOLIDS

Easy-to-administer oral dosage forms, designed for convenience and broad therapeutic use.

Tablets

Solid, stable, and scalable solutions for effective drug delivery.

Capsules

Easy-to-swallow, high-bioavailability formats for targeted therapeutic outcomes.

LIQUID ORALS

Palatable and patient-friendly formulations ideal for pediatric and geriatric use.

Powder for Oral Suspension

Mixable formulations offering flexible and accurate dosing.

STERILE INJECTABLES

Fast-acting, high-purity injectables for reliable drug administration and absorption.

Liquid Injections

Ready-to-use sterile formulations for immediate therapeutic effect.

Powder for Injections

Reconstitutable powders ensuring extended shelf life and stability.

EXTERNAL PREPARATIONS

Topical and ophthalmic solutions tailored for safe and effective external application.

Creams & Ointments

Soothing, skin-friendly formulations for targeted local action.

Eye Drops

Sterile, particle-free solutions for safe eye administration.

30 Years of Growth, Guided

by Purpose

For over three decades, Bharat Parenterals Limited Group has upheld a legacy of innovation, integrity, and nation-building — standing among the earliest advocates of the ‘Make in India’ vision.

Our journey has been defined by strategic investments in R&D, expanding world-class infrastructure, and refining our systems; we've grown from a manufacturing presence into a diversified pharmaceutical group. At every step, we’ve focused on creating value that empowers not only our shareholders and global partners—but also our people, communities, and the healthcare ecosystem at large.

Investors Centre

Annual Reports

Read More

Shareholder Information

Read More

Empowering Lives, Sustaining Futures

Bharat Parenterals’ commitment to sustainability and social impact drives meaningful change — in rural villages, urban centers, and everywhere in between.

Explore Initiatives

Latest At BPL

Research Image
4th September 2025
Bharat Parenterals IPHEX 2025 at New Delhi on September 2025
Read More
Biochemistry Image
26th October 2025
CPHI Frankfurt October 2025
Read More
Diagnostics Image
25th July 2025
MD Mr. Bharat Desai honoured with the prestigious HSBC CNBC-TV18..
Read More